Literature DB >> 27000518

A systematic review of the risks factors associated with the onset and natural progression of spina bifida.

Jennifer Donnan1, Stephanie Walsh2, Lindsey Sikora3, Andrea Morrissey2, Kayla Collins2, Don MacDonald2.   

Abstract

The purpose of this study was to systematically assess and synthesize the world literature on risk factors for the onset and natural progression of spina bifida, thereby providing a basis for policy makers to identify appropriate risk management measures to mitigate the burden of disease in Canada. Searches of several health literature databases from inception to February 2013 were conducted by a health sciences librarian. A total of three meta-analyses that studied a risk factor for the onset of spina bifida were included. Pooled results showed that paternal exposure to Agent Orange (RR=2.02; 95% CI 1.48-2.74) and maternal obesity prior to pregnancy (OR=2.24; 95% CI 1.86-2.74) each increased the risk of having a child with spina bifida. Paternal exposure to organic solvents was also close to the limit of significance (OR=1.59; 95% CI 0.99-2.56). A total of 63 observational studies, encompassing hundreds of potential risk factors, were included for risk factors for the onset of disease. One meta-analysis and four observational studies examined the impact of genetic risk factors. Only specified mutations in the 5,10-methylenetetrahydrofolate reductase (MTHFR) and dihydrofolate reductase (DHFR) genes were found to be linked to disease onset. One observational study evaluated a risk factor for the natural progression of disease. An extensive number of potential risk factors for the onset of spina bifida have been studied, though most lack sufficient evidence to confirm an association. Currently, strong evidence exists to suggest a causal association for maternal obesity prior to pregnancy, and paternal exposure to Agent Orange.
Copyright © 2016. Published by Elsevier B.V.

Entities:  

Keywords:  Onset; Progression; Risk factors; Spina bifida; Systematic review; aetiology

Mesh:

Year:  2016        PMID: 27000518     DOI: 10.1016/j.neuro.2016.03.008

Source DB:  PubMed          Journal:  Neurotoxicology        ISSN: 0161-813X            Impact factor:   4.294


  4 in total

1.  Spina bifida and pediatric cancers.

Authors:  Julia E Heck; Pei-Chen Lee; Chia-Kai Wu; Chung-Yi Li; Di He; Noah Federman; Fei Yu; Jorn Olsen; Beate Ritz; Onyebuchi A Arah; Johnni Hansen
Journal:  Pediatr Hematol Oncol       Date:  2020-05-04       Impact factor: 1.969

Review 2.  Imaging and genetic investigations of neural tube defect in a calf: case report and review of the literature.

Authors:  Giulia Cagnotti; Federica Sammartano; Iride Bertone; Maria Teresa Capucchio; Isabella Nicola; Paola Sacchi; Claudio Bellino; Antonio D'Angelo
Journal:  J Vet Diagn Invest       Date:  2019-01-13       Impact factor: 1.279

3.  Prevalence and time trends of spina bifida in fourteen cities located in the Liaoning province of northeast China, 2006-2015.

Authors:  Gen Ba; Qi-Jun Wu; Yan-Ling Chen; Yan-Hong Huang; Ting-Ting Gong
Journal:  Oncotarget       Date:  2017-03-21

4.  Early prenatal diagnosis of an atypical phenotype of sacral spina bifida.

Authors:  Roxana Elena Bohîlțea; Bianca Margareta Mihai; Octavian Munteanu; Ioniță Ducu; Vasile Adrian Dumitru; Consuela-Mădălina Gheorghe; Tiberiu Augustin Georgescu; Valentin Varlas; Radu Vlădăreanu
Journal:  J Med Life       Date:  2021 Sep-Oct
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.